DERISQ

Owner

Goods & Services

Chemical analysis services; Use of proprietary artificial intelligence on a contract basis with customers to analyze drug molecules using genomic and other biological data with respect to the likelihood of a successful FDA clinical trial of such molecule's safety and efficacy, including potential side effects and toxicity, and, if potential deficiencies are identified, the use of such artificial intelligence to assist in the tailoring of such clinical trials in order to remedy such deficiencies; includes the circumstance in which a clinical trial has already been performed unsuccessfully, the revision of the clinical trial protocol to remedy the deficiency.